Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 Aug 2008 07:00 AM
RNS
Interim Results
27 Aug 2008 04:33 PM
RNS
Notice of Interim Results
18 Aug 2008 10:21 AM
RNS
Notification of Major Interes
15 Aug 2008 01:19 PM
RNS
Rule 2.10 Announcement
15 Aug 2008 11:38 AM
RNS
Rejection of GeneThera's indi
28 Jul 2008 07:00 AM
RNS
Board Appointment
15 Jul 2008 04:13 PM
RNS
TROVAX Phase III TRIST Study
14 Jul 2008 08:48 AM
RNS
TroVax QUASAR Trial
11 Jul 2008 07:00 AM
RNS
RECOMMENDATION FOR TROVAX® PH
01 Jul 2008 09:10 AM
RNS
RESPONSE TO BAVARIAN NORDIC'S
01 Jul 2008 07:00 AM
RNS
Board Changes
24 Jun 2008 07:00 AM
RNS
JEFFERIES HEALTHCARE CONFEREN
02 Jun 2008 07:00 AM
RNS
Trovax Phase II Trial Results
30 May 2008 03:28 PM
RNS
Blocklisting Return
30 May 2008 03:25 PM
RNS
Total Voting Rights Update
27 May 2008 10:25 AM
RNS
FBR Capital Markets Spring In
19 May 2008 07:00 AM
RNS
Rodman & Renshaw Healthcare C
16 May 2008 07:00 AM
RNS
Phase II Trial Results
09 May 2008 01:48 PM
RNS
Annual General Meeting
09 May 2008 07:00 AM
RNS
Interim Management Statement
30 Apr 2008 11:42 AM
RNS
Total Voting Rights
15 Apr 2008 07:00 AM
RNS
Board changes
03 Apr 2008 08:35 AM
RNS
Annual Information Update
01 Apr 2008 04:18 PM
RNS
Major Interest in Shares
31 Mar 2008 10:48 AM
RNS
Total Voting Rights Update
25 Mar 2008 10:06 AM
RNS
New Trovax Clinical Data
18 Mar 2008 09:09 AM
RNS
Major Interest in Shares
17 Mar 2008 12:32 PM
RNS
Presentation at Conference
13 Mar 2008 12:26 PM
RNS
Directors' Interest in Shares
10 Mar 2008 08:52 AM
RNS
Board Appointment
10 Mar 2008 07:02 AM
RNS
Phase III Trist Study
10 Mar 2008 07:01 AM
RNS
Preliminary Results
29 Feb 2008 11:43 AM
RNS
Total Voting Rights Update
20 Feb 2008 07:00 AM
RNS
Phase III Trist Study
19 Feb 2008 04:22 PM
RNS
Holding(s) in Company
15 Feb 2008 09:05 AM
RNS
Major Interest In Shares
13 Feb 2008 12:15 PM
RNS
Major Interest in Shares
07 Feb 2008 07:00 AM
RNS
Notification of Results
01 Feb 2008 10:40 AM
RNS
Notification of Shares
31 Jan 2008 08:57 AM
RNS
Total Voting Rights
30 Jan 2008 08:00 AM
RNS
Notifcation of Shares
23 Jan 2008 09:16 AM
RNS
Major Interest in Shares
22 Jan 2008 07:00 AM
RNS
Development Milestone
18 Jan 2008 12:53 PM
RNS
Notification of Shares
07 Jan 2008 07:00 AM
RNS
Exclusive License Agreement
18 Dec 2007 01:35 PM
RNS
Interest In Shares
13 Dec 2007 07:00 AM
RNS
Phase I/II Trial
10 Dec 2007 12:28 PM
RNS
Major Interest in Shares
10 Dec 2007 07:00 AM
RNS
Trovax Phase III Trial
05 Dec 2007 01:33 PM
RNS
Scrip's Deal of the year

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings